Ovid Therapeutics Inc

Healthcare · Biotechnology

2.40$ -2.1% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

Ovid Therapeutics Inc (OVID) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 232 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet OVID
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	58	53	47	108	98	89	79	69	60	48	67	55	41	81	62	45	92	76	237	218	207	195	191	177	165	155	143	136	125	144	132	118	103	92	82	77	64	151	226	232
Current Assets	58	52	47	107	97	89	76	65	55	44	63	54	39	80	61	44	90	75	237	216	205	190	170	156	140	131	120	102	92	110	93	81	66	56	46	42	29	90	160	124
Cash	58	52	44	106	96	87	29	23	31	36	55	47	38	42	27	41	87	72	233	212	202	188	167	73	58	129	63	72	57	27	31	30	15	26	21	28	21	13	94	11
Cash & Short-Term Investments	58	52	44	106	96	87	74	63	53	42	60	47	38	77	58	41	87	72	233	212	202	188	167	152	138	129	118	97	87	106	90	77	63	53	43	38	26	70	156	117
Receivables	–	0.0	–	–	–	–	–	–	–	–	1.3	1.6	–	1.1	0.4	0.6	0.6	0.1	1.0	–	–	–	1.0	1.0	–	0.3	0.2	–	–	–	–	–	–	–	–	–	–	–	–	–
Inventory	–	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Property, Plant & Equipment	–	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.3	1.2	16	1.1	1.1	1.0	–	–	–	–	–	–	–	–	–	–	–	–
Goodwill	–	–	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	0.0	–	–	0.0	–	0.0	0.0	0.0	0.0	0.0	0.0	-0.1	–	–	–	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Intangible Assets	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.3	0.4	0.4	0.3	0.3	0.4	0.5	0.4	0.4	0.4	0.3	0.3	0.2	0.2	0.2	0.2	0.3	0.3	0.3	0.2	0.3	0.2	0.2	0.1	0.2	0.2	0.1	0.0	–	–	–	–	–
Total Liabilities	2.7	3.7	4.9	7.1	4.6	6.0	6.6	7.5	10	8.8	9.4	9.5	11	11	10	15	28	32	16	11	10	15	26	25	23	23	22	26	24	56	53	29	26	24	22	22	19	20	27	22
Current Liabilities	2.7	3.7	4.9	7.1	4.6	6.0	6.6	7.5	10	8.8	8.1	9.2	10	11	10.0	15	18	22	16	11	10	15	10	9.2	6.7	7.0	6.7	10	8.7	11	8.9	14	12	11	9.3	8.9	6.8	8.3	16	10.0
Short-Term Debt	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.5	0.8	0.9	1.2	1.2	1.3	1.3	1.3	1.3	1.4	1.4	1.4	1.4	1.5	1.5
Accounts Payable	0.5	0.9	1.6	3.6	1.5	2.0	2.4	3.4	4.6	3.8	4.4	2.0	5.3	3.3	4.0	4.6	3.2	5.4	3.1	0.9	3.1	7.1	2.3	4.6	1.0	2.0	1.8	3.8	1.2	3.7	3.6	4.7	2.7	3.2	2.0	4.0	1.7	2.0	8.9	4.1
Long-Term Debt	–	–	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Shareholders' Equity	56	49	42	101	93	83	72	61	50	39	57	45	30	70	51	30	64	44	221	207	197	180	165	152	142	132	121	111	101	88	78	89	76	68	59	56	45	131	198	210
Retained Earnings	-28	-62	-70	-80	-90	-101	-114	-127	-140	-153	-166	-180	-196	-213	-233	-256	-272	-294	-118	-134	-145	-171	-187	-202	-214	-226	-239	-251	-263	-278	-290	-281	-295	-304	-315	-319	-331	-322	-339	-354
Shares Outstanding	20	20	25	18	25	25	25	25	25	25	30	39	39	49	55	56	59	64	67	68	68	68	70	70	70	70	70	71	71	71	71	71	71	71	71	71	71	82	74	74

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings